Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edith Mitchell

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2006
Thymidine phosphorylase expression is associated with response to capecitabine plus irinotecan in patients with metastatic colorectal cancerNeal J Meropol, Philip J Gold, Robert B Diasio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2009
Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology GroupElizabeth Poplin, Yang Feng, Jordan Berlin, et al.
Journal of Medical Ethics|July 9, 2018
Fair, just and compassionate: A pilot for making allocation decisions for patients requesting experimental drugs outside of clinical trialsArthur L Caplan, J Russell Teagarden, Lisa Kearns, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2008
A randomized phase IIIB trial of chemotherapy, bevacizumab, and panitumumab compared with chemotherapy and bevacizumab alone for metastatic colorectal cancerJ Randolph Hecht, Edith Mitchell, Tarek Chidiac, et al.
Cancer Causes & Control : CCC|January 5, 2022
Perceptions of and barriers to cancer screening by the sexual and gender minority community: a glimpse into the health care disparityJoseph Lombardo, Kevin Ko, Ayako Shimada, et al.
Vaccine|March 18, 2003
Monoclonal anti-idiotypic antibody mimicking the gastrointestinal carcinoma-associated epitope CO17-1A elicits antigen-specific humoral and cellular immune responses in colorectal cancer patientsBrigitte Birebent, Edith Mitchell, Nese Akis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2009
Phase III noninferiority trial comparing irinotecan with oxaliplatin, fluorouracil, and leucovorin in patients with advanced colorectal carcinoma previously treated with fluorouracil: N9841George P Kim, Daniel J Sargent, Michelle R Mahoney, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2011
Radiation Therapy Oncology Group 0247: a randomized Phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancerStuart J Wong, Kathryn Winter, Neal J Meropol, et al.
Journal of the National Cancer Institute|July 28, 2022
Leadership Diversity and Development in the Nation's Cancer CentersCaryn Lerman, Chanita Hughes-Halbert, Mary Falcone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2008
Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancerSteven J Cohen, Cornelis J A Punt, Nicholas Iannotti, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2006
Thymidine phosphorylase expression is associated with response to capecitabine plus irinotecan in patients with metastatic colorectal cancerNeal J Meropol, Philip J Gold, Robert B Diasio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2009
Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology GroupElizabeth Poplin, Yang Feng, Jordan Berlin, et al.
Journal of Medical Ethics|July 9, 2018
Fair, just and compassionate: A pilot for making allocation decisions for patients requesting experimental drugs outside of clinical trialsArthur L Caplan, J Russell Teagarden, Lisa Kearns, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2008
A randomized phase IIIB trial of chemotherapy, bevacizumab, and panitumumab compared with chemotherapy and bevacizumab alone for metastatic colorectal cancerJ Randolph Hecht, Edith Mitchell, Tarek Chidiac, et al.
Cancer Causes & Control : CCC|January 5, 2022
Perceptions of and barriers to cancer screening by the sexual and gender minority community: a glimpse into the health care disparityJoseph Lombardo, Kevin Ko, Ayako Shimada, et al.
Vaccine|March 18, 2003
Monoclonal anti-idiotypic antibody mimicking the gastrointestinal carcinoma-associated epitope CO17-1A elicits antigen-specific humoral and cellular immune responses in colorectal cancer patientsBrigitte Birebent, Edith Mitchell, Nese Akis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2009
Phase III noninferiority trial comparing irinotecan with oxaliplatin, fluorouracil, and leucovorin in patients with advanced colorectal carcinoma previously treated with fluorouracil: N9841George P Kim, Daniel J Sargent, Michelle R Mahoney, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2011
Radiation Therapy Oncology Group 0247: a randomized Phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancerStuart J Wong, Kathryn Winter, Neal J Meropol, et al.
Journal of the National Cancer Institute|July 28, 2022
Leadership Diversity and Development in the Nation's Cancer CentersCaryn Lerman, Chanita Hughes-Halbert, Mary Falcone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2008
Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancerSteven J Cohen, Cornelis J A Punt, Nicholas Iannotti, et al.
Pageof 5